Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
about
Liver transplantation for cholangiocarcinoma: Current status and new insightsCurrent diagnostic and management options in perihilar cholangiocarcinomaThe significance of genetics for cholangiocarcinoma developmentCholangiocarcinomaCholangiocarcinoma: Current Knowledge and New DevelopmentsManagement of perihilar cholangiocarcinoma in the era of multimodal therapyClassification, diagnosis, and management of cholangiocarcinomaThe role of the hepatitis viruses in cholangiocarcinomaSurgical options for intrahepatic cholangiocarcinoma.Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.Intrahepatic cholangiocarcinomaSociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care.Pathogenesis, diagnosis, and management of cholangiocarcinomaMutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1.Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United StatesDecitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts.Cohort profile: cholangiocarcinoma screening and care program (CASCAP).The Cholangiopathies.Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinoma.Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencingDiabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis.Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine.Obesity and cholangiocarcinomaOverexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassificationAnnexin A1: A new immunohistological marker of cholangiocarcinoma.Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic siteAre common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics DatabaseSmoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma.
P2860
Q26783361-9E724BCD-45BF-4F5C-9173-1E01403D6C3FQ26822808-6298E438-96CB-4205-8BA6-18A432C4A870Q26865749-F33BB4C8-A3DD-417D-8045-902DA058010DQ27001694-EB35C75A-A118-496A-975A-2AF041F65C02Q28076098-FD8BB0D8-04C0-4C0F-AA05-2786A0C57928Q28273788-63B1F3A1-6D0B-4613-B406-EDFB7AC5CEAEQ28275153-E4274157-27E3-4440-A382-AFB07E1B7D07Q28288613-404D015B-290C-489D-8131-9AEFFA8956FCQ30234462-09132585-4FA1-4FDE-AA7B-ED28DCD0DA7DQ30398077-30D61997-87EA-4EB2-B89B-35A6B07838F0Q33555135-5F6BBC66-30FF-4FF4-A542-03B78E3C42A7Q34277315-464CBC5F-47AD-4188-A392-D4526D898E60Q34656747-63ED8433-109A-4B82-9F1B-3C3B247DC455Q34764681-4193EDDE-3A04-456E-80A6-2C57BF7A9924Q34904867-DCFB08B7-267B-46A4-B6AA-9764E4BF680DQ35151115-F3F59452-5579-48B8-8883-1CE78868B4E3Q35249982-F09E911E-9F3B-4EF6-8619-EE2000CC7896Q35311768-F9F6EB69-13CF-4076-965B-F3839C053F0FQ35693985-AF4D4C42-4FEE-4C26-AA8C-270A5153A8ECQ35942610-DB2A4565-7386-4DF9-B48E-7F585507902EQ35956552-21442063-622E-46EE-BB53-00644DA44138Q36046443-3278848B-B998-4FAA-8E79-D2E2C0695AACQ36113790-E0181300-49AA-4B62-99E5-379F81AFB03AQ36243908-1054C85C-CD19-43F9-93F3-8DD44DBCF81DQ36287599-55C8FF0C-4885-4E4F-90F6-D207D66C48FDQ36502644-BDA1C1BD-C29C-4016-AE59-065D06E64736Q36572469-A629ED31-274D-4A5E-9841-6DAB68B1F4B3Q36622089-8454EA63-AC23-428E-B5E7-5B5261427A65Q36683019-5F098390-452A-4B03-A00E-A1A8DDEC7C16Q36771685-EA611FD1-F34D-48BF-B8EC-3C9540B8499DQ36821610-540BAC5E-6738-4B2A-A2F0-C708156DB6EBQ36884411-895CBED2-9222-497E-BF82-67AE22944AF1Q36962011-10BBD783-FDAB-4AAF-ABEE-2EC3F1BA9F7EQ37018448-6C8A7881-9AD3-47CD-B198-B4EBC43C5BCBQ37246194-4885240F-A8B8-4307-9F61-0456305BE2EAQ37272833-47C9E99E-0079-4795-B7B6-72EE97022E7CQ37408907-55C39BE4-3E91-4255-B8AB-C9E3E86B11D3Q37587269-3EBACD30-4277-4923-B561-B71E47399F18Q37725159-66928BC9-5D8A-4305-8F79-9C7F1D8EEE44Q38076736-5A484F0A-5E66-42D3-AB82-E18322CB750B
P2860
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@en
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@nl
type
label
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@en
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@nl
prefLabel
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@en
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@nl
P2093
P1476
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
@en
P2093
Howard C Thomas
Mireille B Toledano
Nimzing G Ladep
Shahid A Khan
Shireen Emadossadaty
Simon D Taylor-Robinson
P304
P356
10.1016/J.JHEP.2011.11.015
P50
P577
2011-12-13T00:00:00Z